feed,title,long_url,short_url
MarketWatch,Biomarin plans to resubmit its experimental gene therapy for hemophilia A to the FDA in the second quarter,http://www.marketwatch.com/news/story/biomarin-plans-resubmit-its-experimental/story.aspx?guid=%7BE70207F9%2D0B02%2D4AF8%2DA88A%2D1716958F5185%7D&siteid=rss,https://on.mktw.net/3f5Uj0r
MarketWatch,Figs expects Q4 and full-year revenue to come in ahead of expectations,http://www.marketwatch.com/news/story/figs-expects-q4-full-year-revenue/story.aspx?guid=%7BC9112821%2D7F1A%2D452D%2D87A8%2D81CF2F259313%7D&siteid=rss,https://on.mktw.net/3FbBHH0
MarketWatch,Warburg-backed Navitas agrees to sale to Enterprise Products Partners,http://www.marketwatch.com/news/story/warburg-backed-navitas-agrees-sale-enterprise/story.aspx?guid=%7B8F9F81A9%2DB925%2D461C%2D800A%2D0382D2217448%7D&siteid=rss,https://on.mktw.net/3zHHCT2
